Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
192 participants
OBSERVATIONAL
2021-02-17
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1-group A (healthy group negative Giardia or control group),2-group B (positive Giardia or case group)then investigators make estimation for vitamin D in both groups then investigators try to find if there is relation between vitamin D level and Giardia lamblia infections
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Vitamin D3 Alone and in a Combination With Omega-3 on the Association of C-peptide With Glycemic Control
NCT04307784
Human Intervention Study to Increase 25-hydroxyvitamin D Levels
NCT03499327
Vitamin D Level in Recurrent PV
NCT05067699
Effect of Vitamin D Intake in Pregnancy to Prevent Recurrence of Gestational Diabetes
NCT03701087
Assessment of Vitamin D Level in COVID-19
NCT04949412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1-group A (healthy group negative Giardia or control group),2-group B (positive Giardia or case group)then investigators make estimation for vitamin D in both groups then investigators try to find if there is relation between vitamin D level and Giardia lamblia infections
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
1-Group A(Healty group with negative Giardia lamblia or control group) 96 samples
No interventions assigned to this group
Group B
2- Group B(Cases group with positive Giardia lamblia )96 sample
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Sayed Farrag
principlal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammed Sayed Farrag, Demonstrator
Role: PRINCIPAL_INVESTIGATOR
faculty of medicine sohag university
Mohammed Sayed Farrag, Demonstrator
Role: STUDY_DIRECTOR
faculty of medicine sohag university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Sohag University
Sohag, , Egypt
Faculty of Medicine
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Noha Sammer Ahmed, Assist prof
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Noha sammer ahmed, assist prof
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-21-02-17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.